The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea
Published article (1.176Mb)
Access StatusFull text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.
MetadataShow full item record
CitationBloom, David E, Simiao Chen, Michael Kuhn, Mark E Mcgovern, Les Oxley, and Klaus Prettner. "The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea." The Journal of the Economics of Ageing, 2019, p. 100163.
AbstractWe propose a novel framework to analyze the macroeconomic impact of non-communicable diseases. We incorporate measures of disease prevalence into a human capital augmented production function, which enables us to determine the economic burden of chronic health conditions in terms of foregone gross domestic product (GDP). Unlike earlier frameworks, this approach allows us to account for i) variations in human capital for workers in different age groups, ii) mortality and morbidity effects of non-communicable diseases, and iii) the treatment costs of diseases. We apply our methodology to China, Japan, and South Korea, and estimate the economic burden of chronic conditions in five domains (cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, and mental health conditions). Overall, total losses associated with these diseases over the period 2010–2030 are (measured in real USD with the base year 2010) estimated to be $7.7 trillion for China, 3.5 trillion USD for Japan, and 1 trillion USD for South Korea.
Citable link to this pagehttps://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37363165
- SPH Scholarly Articles